Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ponce, PR
NPI
1215127261
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Parque Los Almendros Calle Lady Di, Apt. 33
Ponce, PR, 00716
Phone (787) 677-1904
Medicare paid, 2024
$2,505
50 services
Medicare patients, 2024
24
Average age 75
Drug cost, 2024
$3.4M
15,698 prescriptions
Company payments, 2025
$1,906
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alejandra N Santiago was code 99213 (office e&m - established), 41 times for 20 patients. In total Alejandra N Santiago billed 50 services in 4 codes, and Medicare paid $2,505.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 41 | 20 | $43.52 | $1,784 |
By year: 2022 $5,360 for 98 services; 2023 $4,608 for 86 services; 2024 $2,505 for 50 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alejandra N Santiago prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,796 prescriptions and refills. In total Alejandra N Santiago wrote 15,698 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,796 | 2,210 | 402 | $105K |
| Atorvastatin Calcium Generic | 1,059 | 1,353 | 296 | $8,038 |
| Synjardy Empagliflozin/Metformin Hcl | 865 | 957 | 196 | $583K |
| Glimepiride Generic | 587 | 739 | 158 | $3,934 |
| Metformin Hcl Generic | 534 | 677 | 146 | $2,958 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 532 | 775 | 144 | $54K |
| Trulicity Dulaglutide | 505 | 523 | 79 | $515K |
| Humalog Insulin Lispro | 477 | 639 | 122 | $56K |
| Jardiance Empagliflozin | 461 | 525 | 115 | $321K |
| Levothyroxine Sodium Generic | 386 | 542 | 103 | $3,736 |
| Humalog Mix 50-50 Kwikpen Insulin Lispro Protamin/Lispro | 366 | 415 | 65 | $67K |
| Jentadueto Linagliptin/Metformin Hcl | 354 | 392 | 80 | $207K |
| Losartan Potassium Generic | 352 | 488 | 110 | $3,050 |
| Simvastatin Generic | 351 | 474 | 102 | $2,198 |
| Gabapentin Generic | 215 | 267 | 73 | $2,253 |
Brand drugs: 8,026 claims; generic drugs: 7,009 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alejandra N Santiago $1,906 ($1,906 in general payments such as food, travel and fees) from 10 companies. The largest payer was Sanofi-Aventis U.S. LLC with $504.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 4 | $504 |
| Corcept Therapeutics CORT | 4 | $371 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $302 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $244 |
| Bayer Puerto Rico Inc. BAYN.DE | 5 | $135 |
| Perspectum Diagnostics Ltd | 1 | $117 |
| Lilly USA, LLC LLY | 1 | $112 |
| Amgen Inc. AMGN | 2 | $46.19 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $42.48 |
| Novo Nordisk Inc NVO | 1 | $30.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.